Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on November 1, 2004

Circulation. 2004
Published online before print November 1, 2004, doi: 10.1161/01.CIR.0000146920.35020.44
A more recent version of this article appeared on November 9, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/19/3017    most recent
01.CIR.0000146920.35020.44v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kies, P.
Right arrow Articles by Camici, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kies, P.
Right arrow Articles by Camici, P. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-EPHEDRINE
*PSEUDOEPHEDRINE
Related Collections
Right arrow Nuclear cardiology and PET
Right arrow Arrhythmias, clinical electrophysiology, drugs

Submitted on May 28, 2003
Revised on April 1, 2004
Accepted on April 20, 2004

Abnormal Myocardial Presynaptic Norepinephrine Recycling in Patients With Brugada Syndrome

Peter Kies MD*, Thomas Wichter MD, FESC, Michael Schäfers MD,, Matthias Paul MD, Klaus P. Schäfers PhD, Lars Eckardt MD, Lars Stegger MD, Eric Schulze-Bahr MD, Ornella Rimoldi MD, Günter Breithardt MD, FESC, Otmar Schober MD, PhD, FESC, and Paolo G. Camici MD, FESC, FRCP

From the Department of Nuclear Medicine (P.K., M.S., K.P.S., L.S., O.S.) and the Department of Cardiology and Angiology (T.W., M.P., L.E., E.S.-B., G.B.), University Hospital of Münster, Münster, Germany; the Institute for Arteriosclerosis Research at the University of Münster (T.W., M.S., L.E., E.S.-B., G.B.), Münster, Germany; and MRC Clinical Sciences Centre (P.K., L.S., O.R., P.G.C.), Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom.

* To whom correspondence should be addressed. E-mail: kies{at}uni-muenster.de.

Background--Life-threatening ventricular tachyarrhythmias can occur in young patients without structural heart disease (idiopathic forms). In many patients, these are typically triggered by an increased sympathetic tone, eg, by physical or mental stress. In contrast, in Brugada syndrome, ventricular tachyarrhythmias more often occur during rest or sleep when the vagal tone is predominant. Furthermore, adrenergic agonists can reduce the level of ST-segment elevation, whereas it is increased by parasympathetic agonists or adrenergic antagonists. The aim of this study was to investigate presynaptic and postsynaptic myocardial sympathetic function in patients with Brugada syndrome.

Methods and Results--Nine patients with Brugada syndrome (6 male, 3 female; age, 41±13 years) were enrolled in this study. The cardiac autonomic nervous system was assessed noninvasively, quantifying myocardial presynaptic and postsynaptic sympathetic function by means of positron emission tomography with the norepinephrine analogue 11C-Hydroxyephedrine (11C-HED) and the nonselective {beta}-blocker 11C-CGP 12177 (11C-CGP). Presynaptic sympathetic norepinephrine recycling, assessed by 11C-HED, was globally increased in patients with Brugada syndrome compared with a group of age-matched healthy control subjects (92.9±16.2 mL/g versus 69.1±14.2 mL/g; P<0.05), whereas postsynaptic {beta}-adrenoceptor density, assessed by 11C-CGP, was similar in patients and control subjects (10.4±6.7 pmol/g versus 10.2±2.9 pmol/g; P=NS).

Conclusions--The present study on autonomic innervation in Brugada syndrome describes an enhanced presynaptic norepinephrine recycling with preserved {beta}-adrenoceptor density, further supporting the hypothesis of an autonomic dysfunction in Brugada syndrome. This is a further step toward the understanding of the pathophysiology of the disease with potential future impact on therapeutic strategies.


Key words: fibrillation • death, sudden • nervous system, autonomic • receptors, adrenergic, beta




This article has been cited by other articles:


Home page
Circ Arrhythm ElectrophysiolHome page
A. S. Amin, E. A.A. de Groot, J. M. Ruijter, A. A.M. Wilde, and H. L. Tan
Exercise-Induced ECG Changes in Brugada Syndrome
Circ Arrhythm Electrophysiol, October 1, 2009; 2(5): 531 - 539.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Saraste, S. G. Nekolla, and M. Schwaiger
Cardiovascular molecular imaging: an overview
Cardiovasc Res, September 1, 2009; 83(4): 643 - 652.
[Abstract] [Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
R. L. Verrier and M. E. Josephson
Impact of Sleep on Arrhythmogenesis
Circ Arrhythm Electrophysiol, August 1, 2009; 2(4): 450 - 459.
[Full Text] [PDF]


Home page
EuropaceHome page
M. A. Babaee Bigi, A. Aslani, and A. Aslani
Significance of cardiac autonomic neuropathy in risk stratification of Brugada syndrome
Europace, July 1, 2008; 10(7): 821 - 824.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
T. Wichter
What role for autonomic dysfunction in Brugada Syndrome? Pathophysiological and prognostic implications
Europace, July 1, 2008; 10(7): 782 - 783.
[Full Text] [PDF]


Home page
HeartHome page
J Knuuti and F M Bengel
Positron emission tomography and molecular imaging
Heart, March 1, 2008; 94(3): 360 - 367.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. T. Thackeray, R. S. Beanlands, and J. N. DaSilva
Presence of Specific 11C-meta-Hydroxyephedrine Retention in Heart, Lung, Pancreas, and Brown Adipose Tissue
J. Nucl. Med., October 1, 2007; 48(10): 1733 - 1740.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
F. M. Bengel, P. Ueberfuhr, D. Schafer, S. G. Nekolla, B. Reichart, and M. Schwaiger
Effect of Diabetes Mellitus on Sympathetic Neuronal Regeneration Studied in the Model of Transplant Reinnervation
J. Nucl. Med., September 1, 2006; 47(9): 1413 - 1419.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. G. Meregalli, A. A.M. Wilde, and H. L. Tan
Pathophysiological mechanisms of Brugada syndrome: Depolarization disorder, repolarization disorder, or more?
Cardiovasc Res, August 15, 2005; 67(3): 367 - 378.
[Abstract] [Full Text] [PDF]